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Seoul, South Korea; and New York, New YorkOBJECTIVES The aim of this study was to assess the clinical and morphological predictors for func-
tionally signiﬁcant in-stent restenosis (ISR).
BACKGROUND Although they have been studied de novo in native coronary artery lesions, the re-
lationships between clinical and morphological characteristics and the hemodynamic signiﬁcance of ISR
are not well understood.
METHODS In 175 patients with ISR of a single coronary artery (angiographic stenosis >50%), we
compared quantitative coronary angiography and intravascular ultrasound (IVUS) with stress myocardial
single-photon emission computed tomography (SPECT). A positive SPECT was a reversible perfusion
defect in the territory of the ISR artery.
RESULTS Overall, 103 (59%) patients had a positive SPECT. In-segment IVUS minimal lumen area
(MLA) was signiﬁcantly smaller in lesions with positive SPECT compared with negative SPECT
(1.7  0.5 mm2 vs. 2.4  0.8 mm2, p < 0.001). Stent underexpansion (minimal stent area <5.0 mm2)
was more common in the positive SPECT group than in the negative SPECT group (52% vs. 32%,
p ¼ 0.010). A positive SPECT was seen in 54% (65 of 121) of focal ISR lesions compared with 70% (38
of 54) of multifocal or diffuse ISR lesions as assessed by IVUS (p ¼ 0.039). Independent determinants
for a positive SPECT were diabetes (odds ratio [OR]: 2.41; 95% conﬁdence interval [CI]: 1.02 to 5.68;
p ¼ 0.046), in-segment angiographic diameter stenosis (OR: 1.06; 95% CI: 1.03 to 1.09; p < 0.001), in-
segment IVUS-MLA (OR: 0.30; 95% CI: 0.14 to 0.63; p ¼ 0.001), stent underexpansion (minimal stent
area <5.0 mm2), (OR: 2.91; 95% CI: 1.19 to 7.07; p ¼ 0.019), proximal location of the IVUS-MLA (OR:
4.62; 95% CI: 1.75 to 12.18; p ¼ 0.002), and a multifocal or diffuse ISR pattern (OR: 2.50; 95% CI: 0.99
to 6.28; p ¼ 0.050). An in-segment angiographic diameter stenosis $69.5% (72% sensitivity, 74% spec-
iﬁcity, area under the curve ¼ 0.793) and an IVUS-MLA #1.9 mm2 (67% sensitivity, 75% speciﬁcity, area
under the curve ¼ 0.756) best predicted a positive SPECT; however, the overall diagnostic accuracies
were only 73% and 70%, respectively.
CONCLUSIONS In lesions with ISR, neither angiography nor IVUS accurately predicted an abnormal
SPECT. (J Am Coll Cardiol Img 2013;6:1183–90) ª 2013 by the American College of Cardiology
Foundation
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1184he clinical decision whether to treat coronary and was determined after evaluating both clinical and
artery in-stent restenosis (ISR) should be
based on symptoms and objective evidence of
ischemia (1–3). In native coronary artery
stenoses, the angiographic and intravascular ultra-
sound (IVUS) predictors for ischemia have been
reported (4–6). However, there are few studies
showing the relationship between the clinical and
morphological features of ISR and its hemodynamic
signiﬁcance. Thus, we performed an integrated
analysis of quantitative coronary angiography, IVUS,
and myocardial perfusion imaging to assess the
clinical and anatomic factors determining the func-
tional signiﬁcance of an ISR lesion in patients with
single-vessel disease.
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issionStudy population. Between January 2007
and December 2011, 290 patients with an
ISR lesion within the proximal or mid
segment of a single epicardial coronary
artery underwent both IVUS and stress
myocardial single-photon emission com-
puted tomography (SPECT). Exclusion
criteria were the presence of 2- or 3-vessel
disease (i.e., a stenosis in another vessel) or
multiple stenoses (angiographic stenosis
[diameter stenosis (DS)] >50% on visual
estimation) within the target vessel that
would complicate the interpretation of the
SPECT images, the presence of a bypass
graft, ISR within a side branch, acute
myocardial infarction, scarred myocar-
dium or regional wall motion abnormality,
left ventricular ejection fraction<50%, leftmain coronary artery stenosis >30%, the presence of
a ﬁxed perfusion defect on SPECT, and cases in
which the IVUS imaging catheter failed to cross the
ISR lesion. ISR lesions with total occlusion were
excluded except in 4 patients in whom guidewire
passage restored coronary ﬂow, and IVUS examina-
tion could be completed. Thus, a total of 175 patients
with a single ISR lesion and no other coronary ste-
nosis were included in the current analysis. Treat-
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Angiographic analysis. Quantitative coronary angi-
ography was performed using standard techniques
with automated edge-detection algorithms (CAAS-
5, Pie Medical, Maastricht, the Netherlands) in the
angiographic analysis center of the CardioVascular
Research Foundation, Seoul, South Korea. Angio-
graphic restenosis was deﬁned as DS >50% at
follow-up angiography and classiﬁed as suggested by
Mehran et al. (7). The minimal lumen diameter
(MLD) was measured within the stent (in-stent),
within the 5-mm-long proximal and distal segments
adjacent to the edges of the stent, and within the
segment that included the proximal and distal
5-mm-long reference segments as well as the stent
(in-segment).
IVUS imaging and analysis. After intracoronary ad-
ministration of 0.2 mg nitroglycerin, IVUS imaging
was performed using motorized transducer pullback
(0.5 mm/s) and a commercial scanner (Boston
Scientiﬁc/SCIMED,Minneapolis,Minnesota)with a
rotating, 40-MHz transducer within a 3.2-F imaging
sheath. Using computerized planimetry (EchoPlaque
3.0, Indec Systems, Mountain View, California),
ofﬂine quantitative IVUS analysis was performed in
a core laboratory at the Asan Medical Center. In-
stent measurements were obtained every 1 mm and
included the external elastic membrane, stent, lumen
(intrastent lumen bounded by the borders of the
stent and intimal hyperplasia [IH]), and IH (stent
minus intrastent lumen) areas. The percentage of IH
(%IH) was deﬁned as the IH area divided by the
stent area. Volumes were calculated using Simpson’s
rule and then normalized for analysis length
(normalized volume). Stent underexpansion was
deﬁned as minimal stent area <5 mm2 (8,9). The
external elastic membrane and the smallest lumen
areas were measured within the 5-mm-long reference
segments proximal and distal to the stent edges. In
parallel with angiographic measurements, both in-
stent and in-segment (stent plus 5-mm-long refer-
ence segment) minimum lumen areas (MLAs) were
identiﬁed and measured. According to the longitu-
dinal distribution of signiﬁcant IH assessed by
IVUS, ISR patterns were classiﬁed as follows: 1) focale, Asan Medical Center, Seoul, South Korea; yDepartment of
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1185ISR was deﬁned as %IH >50% and #10 mm in
length; 2) multifocal ISR contained multiple focal
areas of ISR; and 3) diffuse ISR was deﬁned as %IH
>50% and >10 mm in length.
Stent malapposition was deﬁned as separation of
at least 1 stent strut not in contact with the intimal
surface of the vessel wall that was not overlapping a
side branch with evidence of blood speckling behind
the strut (8).
Myocardial perfusion imaging. Gated thallous chlo-
ride (Tl-201) SPECT images were acquired after
adenosine stress testing (post-stress SPECT) and
again 4 h after the injection of Tl-201 chloride
(redistribution SPECT). Patients abstained from
caffeine-containing foods and beverages and drugs
such as aminophylline and theophylline 24 h before
the test. Adenosine was intravenously administered
at a rate of 140 mg/kg/min for 6 min. Three mi-
nutes after the initiation of the adenosine infusion,
a dose of Tl-201 (range, 92.5 to 148 MBq, as
determined by the subject’s body weight) was
injected intravenously. Six minutes after adenosine
infusion, post-stress myocardial perfusion images
were acquired with a 2-head gamma camera
(Ecam, Siemens, Munich, Germany) equipped with
low-energy all-purpose collimators (64  64 matrix,
32 projections over 180 degrees, 8 frames per cardiac
cycle, 50 s per projection). A zoom factor of 1.78 was
used. The pixel size was 5.4 mm. Transaxial slices
were reconstructed with a Butterworth ﬁlter (order
5; cutoff frequency, 0.35). No attenuation or scatter
correction was applied. Stress and rest tomographic
images were displayed side by side in the short-axis,
horizontal long-axis, and vertical long-axis recon-
struction panels.
A 16-segment model was used in which myocar-
dial segments were allocated to the territories of the
different coronary arteries, as previously described
(10,11). Apical segments were counted as defects
only when contiguous with adjacent abnormal
myocardial segments. Each vascular territory was
classiﬁed as showing no perfusion defect if all seg-
ments in the territory had normal quantitative
uptake. A vascular territory was considered a perfu-
sion defect if quantitative tracer uptake in any
segment within the vascular territory on the stress
image was <75%. Each territory with a perfusion
defect was further classiﬁed as reversible if any of the
segments with a stress defect quantitatively improved
tracer uptake on the image at rest or ﬁxed if any of the
segments with a stress defect showed no change or a
further decrease in tracer uptake on the image at
rest. Lesions with a ﬁxed perfusion defect were
excluded in the analysis. Accordingly, the result wasconsidered positive (positive SPECT) when a revers-
ible perfusion defect or negative (negative SPECT)
when a no perfusion defect was allocated to the
perfusion territory of the target coronary artery (12).
Statistical analysis. All statistical analyses were per-
formed using SPSS software (version 10.0, SPSS
Inc., Chicago, Illinois). Continuous variables were
expressed as mean  1 SD or median and inter-
quartile range and compared using an unpaired
Student t test or the nonparametric Mann-Whitney
test. Categorical variables were presented as counts
and percentages and compared using chi-square
statistics or the Fisher exact test.
Receiver-operating characteristic curves were
analyzed to assess the best cutoff values of the
angiographic and IVUS parameters to predict posi-
tive SPECT with maximal accuracy and using
MedCalc Software (MedCalc Software, Mariakerke,
Belgium). The optimal cutoff was calculated using
the Youden index. The sensitivity, speciﬁcity, posi-
tive predictive value (PPV), and negative predictive
value (NPV) with their 95% conﬁdence interval (CI)
were determined. Binary logistic regression analysis
was performed to identify the independent de-
terminants of positive SPECT. Candidate variables
with a p value <0.2 on univariate analysis were
included in multivariable model. The ﬁnal models
were determined by a backward variable selection
approach in which the least signiﬁcant variable was
removed one by one after ﬁtting a full model with
the candidate variables. A p value <0.05 was
considered statistically signiﬁcant.
RESULTS
Baseline characteristics. The clinical characteristics
of the 103 patients with a positive SPECT and the
72 patients with a negative SPECT were compared
in Table 1. There was no difference in total stent
length or duration since stent implantation between
the 2 groups. A positive SPECT was more frequent
in diabetic patients than in nondiabetic patients
(70% vs. 51%, p ¼ 0.010). There was no signiﬁcant
difference in the frequency of a positive SPECT
between bare metal and drug-eluting ISR lesions
(71% vs. 56%, p ¼ 0.091). Additionally, the fre-
quency of a positive SPECT was not different
among the vessels (60% in the left anterior
descending artery, 62% in the left circumﬂex artery,
and 53% in the right coronary artery; p ¼ 0.727).
Quantitative coronary angiographic data. Compared
with ISR lesions with a negative SPECT, ISR
lesions with a positive SPECT had a smaller in-
stent and in-segment minimal lumen diameter
Table 1. Baseline Clinical Characteristics
Thallium Positive
(n [ 103)
Thallium Negative
(n [ 72) p Value
Age, yrs 62 (55–70) 64 (57–70) 0.607
Male 75 (73) 53 (74) 0.907
Diabetes 50 (49) 21 (29) 0.010
Hypertension 66 (64) 40 (56) 0.256
Smoking 45 (44) 40 (56) 0.122
Hyperlipidemia 79 (77) 54 (75) 0.796
Previous PCI 22 (21) 9 (13) 0.131
Renal failure 7 (7) 1 (1) 0.092
Ejection fraction, % 60.0 (55.0–63.0) 60.0 (59.0–63.5) 0.052
Clinical manifestation
Asymptomatic 23 (22) 32 (44)
Stable angina 51 (50) 24 (34) 0.678
Unstable angina 29 (28) 16 (22)
No. of stents 1.0 (1.0–2.0) 1.0 (1.0–2.0) 0.151
Stent length, mm 31.2 (23.1–44.6) 29.0 (19.6–43.2) 0.283
Stent types
Bare metal 25 (24) 10 (14)
0.091
Drug eluting 78 (76) 62 (86)
Follow-up duration, mo 36.6 (15.7–74.4) 27.7 (8.9–57.8) 0.175
Values are median (interquartile range) compared by Mann-Whitney test, or n (%).
PCI ¼ percutaneous coronary intervention.
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1186(MLD) and a greater in-stent and in-segment DS
(Table 2). Lesions with a positive SPECT also had
a smaller MLD and a greater DS within the prox-
imal 5-mm-long reference segments and more
frequent proximal edge restenosis (23% vs. 10%, p¼
0.021). Finally, a positive SPECT study for ischemia
was more frequently seen in ISR lesions with a pro-
liferative or total occlusion type of ISR comparedwith
lesions with other more focal patterns of ISR (86%
[18 of 21] vs. 55% [85 of 154], p ¼ 0.008).
On receiver-operating characteristic curve anal-
ysis, an in-segment angiographic DS $69.5% best
predicted a positive SPECT with 72% sensitivity,
74% speciﬁcity, a PPV of 80%, and an NPV of 65%
(area under the curve [AUC] ¼ 0.793; 95% CI:
0.725 to 0.850, p < 0.001). The overall diagnostic
accuracy was 73% (Fig. 1).
There was no difference in in-segment MLD
(1.0  0.5 mm vs. 1.0  0.5 mm) or in-segment DS
(69.2  16.2% vs. 68.6  16.5%) or angiographic
restenosis pattern between diabetic and nondiabetic
patients (all p values >0.05).
IVUS ﬁndings. Within both the proximal and distal
reference segments, a smaller lumen area and a
larger plaque burden were more frequently seen inISR lesions with a positive SPECT than in those
with a negative SPECT (Table 2). Compared with
the negative SPECT group, ISR lesions with pos-
itive SPECT showed a smaller in-stent MLA and
normalized in-stent lumen volume and a greater
%IH at the MLA site. In-segment MLA was
signiﬁcantly smaller in lesions with a positive
SPECT compared with a negative SPECT (1.7 
0.5 mm2 vs. 2.4  0.8 mm2, p < 0.001). Stent
underexpansion (minimal stent area <5.0 mm2)
was more common in the positive SPECT group
than in the negative SPECT group (52% vs. 32%,
p ¼ 0.010). Conversely, there was no signiﬁcant
difference in the stent vessel wall malapposition rate
between the 2 groups (8% vs. 3%, p ¼ 0.162).
A positive SPECT was more frequent in ISR
lesions in which the MLA site was located within
the proximal one-third of the stented segment
compared with the mid one-third or the distal one-
third (80% vs. 54% vs. 42%, p < 0.001). A positive
SPECT was seen in 54% (65 of 121) of focal
ISR lesions versus 70% (38 of 54) of multifocal or
diffuse ISR lesions as assessed by IVUS (p ¼ 0.039).
On receiver-operating characteristic curve anal-
ysis, an in-segment MLA #1.9 mm2 was the best
cutoff value that predicted a positive SPECT with
67% sensitivity, 75% speciﬁcity, a PPV of 79%, and
an NPV of 61% (AUC ¼ 0.756, 95% CI: 0.685 to
0.818, p ¼ 0.001). The overall diagnostic accuracy
was 70% (Fig. 1). Furthermore, there was no dif-
ference in the in-segment MLA cutoff between bare
metal stent (1.9 mm2, AUC ¼ 0.756) and the drug-
eluting stent (1.9 mm2, AUC ¼ 0.753) subgroups.
There was no difference in the average reference
lumen area between diabetic and nondiabetic patients
(4.6  2.2 mm2 vs. 4.6  2.0 mm2), in-segment
MLA (2.0  0.7 mm2 vs. 1.9  0.7 mm2), %IH
(64.9  20.4% vs. 66.4  18.6%), or minimal
stent area (5.3  1.6 mm2 vs. 5.6  1.7 mm2)
(all p values >0.05).
Independent determinants of a positive SPECT. The
independent factors associated with a positive
SPECT were diabetes, angiographic in-segment
DS, IVUS in-segment MLA, stent underexpansion
(minimal stent area <5.0 mm2), location of the
IVUS-MLA site, and an IVUS multifocal or diffuse
pattern of ISR (C-statistic ¼ 0.879) (Table 3).
Treatment of ISR. Repeat revascularization was
performed in 96 patients (93%) with a positive
SPECT and 38 (53%) with a negative SPECT.
Among the treated patients, despite the negative
SPECT, 6 patients were asymptomatic, and the
remaining 32 patients had angina symptoms at the
time of ISR detection. Overall, 36 lesions (95%)
Table 2. Quantitative Angiographic and IVUS Findings
Thallium Positive
(n [ 103)
Thallium Negative
(n [ 72) p Value
Angiographic data
Proximal reference MLD, mm 2.4 (1.3–3.0) 2.7 (2.4–3.1) 0.016
Proximal reference DS, % 24.0 (13.0–61.0) 17.0 (7.8–27.0) 0.001
Distal reference MLD, mm 2.0 (1.7–2.4) 2.1 (1.7–2.5) 0.179
Distal reference DS, % 22.0 (13.0–34.0) 21.0 (12.0–39.0) 0.931
In-stent MLD, mm 0.9 (0.6–1.3) 1.5 (1.1–1.9) <0.001
In-stent DS, % 73.0 (56.0–84.0) 53.5 (39.3–62.0) <0.001
In-segment MLD, mm 0.7 (0.5–1.1) 1.3 (0.9–1.6) <0.001
In-segment DS, % 0.7 (0.5–1.1) 57.0 (51.0–70.0) <0.001
Restenosis pattern
Marginal 17 (16) 18 (25)
0.138
Focal body 47 (46) 35 (49)
Multifocal 5 (5) 4 (5)
Diffuse in-stent 16 (15) 12 (17)
Proliferative 14 (14) 3 (4)
Total occlusion 4 (4) 0 (0)
IVUS data
Proximal reference segment
Lumen area, mm2 4.4 (2.3–7.1) 6.4 (5.1–8.3) <0.001
EEM area, mm2 14.1 (11.5–18.1) 14.9 (12.5–18.8) 0.353
Plaque burden, % 66.3 (57.5–80.7) 55.5 (46.1–62.7) <0.001
Distal reference segment
Lumen area, mm2 3.0 (2.0–4.1) 4.1 (2.8–5.7) 0.001
EEM area, mm2 7.8 (5.7–10.3) 9.0 (6.1–13.3) 0.080
Plaque burden, % 60.9 (47.4–71.9) 52.9 (38.9–69.0) 0.027
In-stent segment
MLA within stent, mm2 1.7 (1.3–2.2) 2.4 (1.9–3.3) <0.001
EEM area at the MLA site, mm2 14.6 (11.8–18.0) 13.5 (10.8–18.2) 0.284
Stent area at the MLA site, mm2 7.0 (5.3–8.6) 6.8 (5.4–8.3) 0.952
%IH at the MLA site, % 74.6 (63.3–82.2) 63.1 (52.7–73.3) <0.001
Minimal stent area, mm2 5.0 (4.1–6.3) 5.8 (4.7–6.8) 0.034
In-stent volumetric data
Normalized lumen volume, mm2 4.5 (3.8–5.6) 5.3 (4.0–6.5) 0.016
Normalized EEM volume, mm2 14.4 (12.2–17.4) 14.6 (12.8–17.4) 0.446
Normalized stent volume, mm2 7.0 (5.6–8.2) 7.7 (6.1–8.9) 0.039
Normalized IH volume, mm2 1.9 (1.2–3.6) 1.9 (1.3–2.8) 0.985
%IH volume, mm2 (18.7–46.5) 26.1 (16.0–39.4) 0.309
IVUS-deﬁned ISR pattern
Focal 65 (63) 56 (78)
0.080Multifocal 18 (18) 6 (8)
Diffuse 20 (19) 10 (14)
Values are median (interquartile range), compared by Mann-Whitney test, or n (%).
DS ¼ diameter of stenosis; EEM ¼ external elastic membrane; IH ¼ intimal hyperplasia; %IH ¼ percentage
of intimal hyperplasia; ISR ¼ in-stent restenosis; IVUS ¼ intravascular ultrasound; MLA ¼ minimal lumen
area; MLD ¼ minimal lumen diameter.
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1187had an angiographic DS >70%, and all had an
IVUS MLA <4.0 mm2.
D I SCUSS ION
The major ﬁndings of this study were the following:
1) even in patients with angiographic ISR (DS
>50%), 41% showed no ischemia as assessed by
SPECT imaging; 2) the independent determinants
of a positive SPECT were diabetes, severity of the
angiographic DS, a smaller IVUS-MLA, proximal
location of the IVUS-MLA, stent underexpansion,
and multifocal or diffuse patterns of ISR assessed by
IVUS; 3) an in-segment angiographic DS $69.5%
and an IVUS-MLA #1.9 mm2 best predicted a
positive SPECT, although the overall diagnostic ac-
curacy was only 73% and 70%, respectively. This was
similar in bare metal and drug-eluting ISR lesions.
Previous data reported that ischemia-guided
treatment of ISR lesions led to favorable clinical
outcomes (13,14). However, as has been shown in
many studies, coronary angiography often under-
estimated or overestimated the functional severity of
de novo lesions (1,2,4,5,15), and visual-functional
mismatches were encountered in as many as 40%
of de novo native coronary lesions (6,16). Approx-
imately half of patients with angiographic ISR have
been reported to be asymptomatic (17,18). In our
current study, 41% of the ISR lesions with an
angiographic DS >50% and 20% of the ISR lesions
with an angiographic DS >70% were not associated
with ischemia, as shown by a negative SPECT
study. When operator decision making is based on
the angiographic ﬁndings alone, those patients
without functionally signiﬁcant ISR may undergo
unnecessary clinically driven repeat revasculariza-
tion, as has been shown in randomized trials with
both angiographic and clinical follow-up (19). Our
current data expanded previous observations that
routine angiographic follow-up led to an oculoste-
notic reﬂex and increasing target lesion and target
vessel revascularization rates compared with clinical
follow-up alone (19).
Previous studies provided limited information
regarding patients with ISR lesions that were more
likely to be functionally signiﬁcant and cause
ischemia. Nam et al. (14) reported that angiographic
MLD, DS, and lesion length are related to a frac-
tional ﬂow reserve <0.80 in ISR lesions. Koch et al.
(20) reported that the independent predictors of a
reversible perfusion defect on SPECT imaging are
the angiographic DS and a resting perfusion defect.
Even though ISR lesions tended to be less complex
and less eccentric, previous studies did not support
A B C
D E F
Figure 1. Receiver-Operating Characteristic Curve Analysis for the Prediction of a Positive SPECT
(A) An in-segment angiographic diameter stenosis $69.5% best predicted a positive SPECT (72% sensitivity, 74% speciﬁcity, 80% PPV, 65%
NPV). (B) The cutoff of in-segment minimal lumen diameter was #1.1 mm (77% sensitivity, 68% speciﬁcity, 78% PPV, 67% NPV). (C) An in-
segment minimal lumen area (MLA)#1.9 mm2 was the best cutoff value to predict a positive SPECT (67% sensitivity, 75% speciﬁcity, 79% PPV,
61% NPV). (D) The cutoff of in-stent MLA was#2.1 mm2 (69% sensitivity, 70% speciﬁcity, 62% PPV, 77% NPV). (E) The cutoff of %IH at the MLA
site was $68% (67% sensitivity, 69% speciﬁcity, 60% PPV, 75% NPV). (F) The cutoff of a minimal stent area was #5.1 mm2 (67% sensitivity,
54% speciﬁcity, 51% PPV, 71% NPV). AUC ¼ area under the curve; CI ¼ conﬁdence interval; %IH ¼ percentage of intimal hyperplasia; MLA ¼
minimal lumen area; NPV ¼ negative predictive value; PPV ¼ positive predictive value; SPECT ¼ single-photon emission computed
tomography.
Table 3. Multivariab
Diabetes
In-segment DS
In-segment IVUS-MLA
Stent underexpansion
Proximal one-third loc
Multifocal or entirely
Multivariable analysis inc
diameter (mm), angiograp
IVUS-MLA (mm2), MLA lo
area <5.0 mm2), in-stent
restenosis.
CI ¼ conﬁdence interval
abbreviations as in Table
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1188the hypothesis that greater angiographic DS severity
was necessary to create ischemia compared with de
novo native coronary lesions (20–22). The threshold
of the angiographic DS causing reversible perfusion
defects was found to be similar between ISR (53%,le Analysis for the Prediction of Positive SPECT
OR 95% CI p Value
2.41 1.02–5.68 0.046
1.06 1.03–1.09 <0.001
0.30 0.14–0.63 0.001
2.91 1.19–7.07 0.019
ation of the MLA 4.62 1.75–12.18 0.002
diffuse stenosis 2.50 0.99–6.28 0.050
luded diabetes, in-segment angiographic DS (%), in-segment minimal lumen
hic involvement of proximal edge, percentage of intimal hyperplasia, in-segment
cation at proximal one-third of the stent, stent underexpansion (minimal stent
normalized lumen volume (mm2), and multiple stenosis or entire diffuse in-stent
; OR ¼ odds ratio; SPECT ¼ single-photon emission computed tomography; other
2.AUC ¼ 0.63) and de novo native coronary lesions
(53%, AUC ¼ 0.61) (20). Similarly, compared with
a fractional ﬂow reserve <0.75, the cutoff value of
the angiographic DS was 57% for de novo native
coronary lesions (80% sensitivity, 83% speciﬁcity)
and 55% for ISR lesions (81% sensitivity, 81%
speciﬁcity) (22). Our current study showed that an
in-segment angiographic DS$69% best predicted a
positive SPECT (72% sensitivity, 74% speciﬁcity).
Additionally, a positive SPECT was more frequently
observed in lesions with a proliferative or total oc-
clusion type of ISR compared with the lesions with
other more focal patterns.
The current IVUS analysis expanded on these
angiographic studies to show that more severe and
extensive ISR lesions as well as lesions with stent
underexpansion were more likely to be ischemia
producing. The following IVUS parameters were
related to ischemia: more severe reference segment
disease, a smaller MLA, a greater %IH, stent
underexpansion, an IVUS-MLA that was located in
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1189the proximal one-third of the stented segment, and
a more severe semiquantitative pattern of ISR
(multifocal or diffuse pattern). The best cutoff that
predicted a positive SPECT was an IVUS in-
segment MLA #1.9 mm2; this was similar to the
previously reported MLA of #2.1 mm2 that best
predicted a positive SPECT in de novo native cor-
onary lesions (12). However, with an overall diag-
nostic accuracy of only 70%, the IVUS-MLA did
not improve on the ability of the angiographic DS to
predict a positive SPECT. Anatomic lesion severity,
regardless of the way in which it was assessed, was
only one of the multiple determinants of ischemia,
whether in de novo stenoses or in ISR lesions.
Although there was no difference in angiographic
and IVUS lesion characteristics between diabetic
and nondiabetic patients in the current study, dia-
betic patients more frequently had a positive SPECT
for a given stenosis severity. Moreover, diabetes was
the only clinical predictor of a positive SPECT.
Previous data suggested that the impairment of
endothelium-dependent vasodilation in the coronary
microvasculature was associated with abnormal
myocardial perfusion in diabetic patients (23–25).
Study limitations. To avoid false-negative SPECT
from balanced ischemia, we included only patients
with single-vessel ISR with no other stenosis.
Therefore, the results could not be applied tomultivessel disease or left main coronary artery dis-
ease. Second, most of the ISR lesions with very tight
stenosis or total occlusions were excluded due to the
technical difﬁculty of an IVUS examination. Third,
the optimal treatment strategies for restenotic lesions
and long-term clinical outcomes were not evaluated.
Fourth, a positive SPECT does not always mean
ischemia, whereas a negative SPECT does not always
exclude ischemia. SPECT has limitations such as
scatter or attenuation artifacts and spatial resolution,
and a positive SPECT reﬂects nonuniform distri-
bution of the tracer and not necessarily myocardial
ischemia. Finally, the impact of in-stent neointimal
tissue characteristics (i.e., neoatherosclerosis) on he-
modynamic signiﬁcance was not assessed.CONCLUS IONS
In ISR lesions, neither angiography nor IVUS
accurately predicted the hemodynamic signiﬁcance
as assessed by SPECT imaging. Therefore, decision
making for the treatment of ISR lesions should not
be based on anatomic assessment alone.
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